Nature Communications (Jul 2023)

High throughput single cell long-read sequencing analyses of same-cell genotypes and phenotypes in human tumors

  • Cheng-Kai Shiau,
  • Lina Lu,
  • Rachel Kieser,
  • Kazutaka Fukumura,
  • Timothy Pan,
  • Hsiao-Yun Lin,
  • Jie Yang,
  • Eric L. Tong,
  • GaHyun Lee,
  • Yuanqing Yan,
  • Jason T. Huse,
  • Ruli Gao

DOI
https://doi.org/10.1038/s41467-023-39813-7
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 12

Abstract

Read online

Abstract Single-cell nanopore sequencing of full-length mRNAs transforms single-cell multi-omics studies. However, challenges include high sequencing errors and dependence on short-reads and/or barcode whitelists. To address these, we develop scNanoGPS to calculate same-cell genotypes (mutations) and phenotypes (gene/isoform expressions) without short-read nor whitelist guidance. We apply scNanoGPS onto 23,587 long-read transcriptomes from 4 tumors and 2 cell-lines. Standalone, scNanoGPS deconvolutes error-prone long-reads into single-cells and single-molecules, and simultaneously accesses both phenotypes and genotypes of individual cells. Our analyses reveal that tumor and stroma/immune cells express distinct combination of isoforms (DCIs). In a kidney tumor, we identify 924 DCI genes involved in cell-type-specific functions such as PDE10A in tumor cells and CCL3 in lymphocytes. Transcriptome-wide mutation analyses identify many cell-type-specific mutations including VEGFA mutations in tumor cells and HLA-A mutations in immune cells, highlighting the critical roles of different mutant populations in tumors. Together, scNanoGPS facilitates applications of single-cell long-read sequencing technologies.